Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Current Drug Abuse Reviews|January 28, 2012
Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectivesPaolo Mannelli, Kathleen S Peindl, Tong Lee, et al.
Drug and Alcohol Dependence|March 20, 2018
Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetesLi-Tzy Wu, Udi E Ghitza, He Zhu, et al.
Biological Psychiatry|August 18, 2004
Chronic very low dose naltrexone administration attenuates opioid withdrawal expressionPaolo Mannelli, Edward Gottheil, James F Peoples, et al.
The American Journal on Addictions|March 14, 2009
Early outcomes following low dose naltrexone enhancement of opioid detoxificationPaolo Mannelli, Ashwin A Patkar, Kathleen Peindl, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 1, 2019
Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental IllnessRoger Vilardaga, Javier Rizo, Paige E Palenski, et al.
Annals of Emergency Medicine|March 20, 2012
Alcohol and drug use disorders among adults in emergency department settings in the United StatesLi-Tzy Wu, Marvin S Swartz, Zunyou Wu, et al.
The American Journal of Drug and Alcohol Abuse|April 6, 2006
Changes in tobacco smoking following treatment for cocaine dependenceAshwin A Patkar, Paolo Mannelli, Kathleen Peindl, et al.
Psychopharmacology|January 19, 2006
Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patientsAshwin A Patkar, Paolo Mannelli, Kathleen Peindl, et al.
Journal of Clinical Psychopharmacology|September 18, 2007
Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependencePaolo Mannelli, Ashwin A Patkar, Kathleen Peindl, et al.
Pageof 8